The SEGA instrument has demonstrated good performance in screening for frailty. However, its predictive ability in elderly patients presenting with acute coronary syndrome have never been evaluated. We aimed to study the prognostic value at one year of the frailty level assessed by the SEGA instrument, in a population of patients aged 80 years old or more hospitalized for acute coronary syndrome. All consecutive patients aged 80 years or older hospitalised for myocardial infarction type 1 between November 2016 and October 2017 were included. All underwent standardized geriatric assessment including estimation of frailty by the SEGA instrument. The primary outcome was the time to death from any cause. In all 64 patients were included for a mean age of 85.3±4 years. Using the SEGA instrument, 24% patients were classified “frail” and 44% “very frail”; 18 (28%) deaths were observed during follow-up. When adjusted for patient age, body mass index and arterial hypertension, survival status was not significantly related with frailty status (HR=1.1, 95% CI=0.4-3.1, p=0.8).
💡Rx of cardiac sarcoidosis using immunosupression is essential maintainance therapy— Dr. Purvi Parwani (@purviparwani) September 12, 2019
💡D/C of the Rx associated with radiological relapse https://t.co/ZapSUbsHnm
Thanku4 leading it @DRosenth_
@TahmeedC @rahul3000 @PrashSanders @netta_doc @DrSuzyFeigofsky @rbcasado pic.twitter.com/qewkJkyLY0